Cargando…

Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report

Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a rare autosomal dominant disorder that results from a germline mutation in the fumarate hydratase (FH) gene; it manifests as cutaneous leiomyomas, uterine fibroids, and renal cell cancer (RCC). Patients with HLRCC-associated RCC (HLRCC-RCC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tao, Huang, Yan, Huang, Xing, Lv, Zheng, Tian, Shuo, Ma, Xin, Zhang, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554149/ https://www.ncbi.nlm.nih.gov/pubmed/34722283 http://dx.doi.org/10.3389/fonc.2021.735077

Ejemplares similares

Hereditary leiomyomatosis and renal cell cancer (HLRCC): A case report
por: Yonamine, Tomoko, et al.
Publicado: (2020)

Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC)
por: Gurruchaga Sotés, Ibon, et al.
Publicado: (2021)

Rare variant in the fumarate hydratase gene found in patients with clinical features of hereditary leiomyomatosis and renal cell cancer (HLRCC): A case series
por: Franke, Keith, et al.
Publicado: (2022)

Hereditary leiomyomatosis and renal cell carcinoma
por: Schmidt, Laura S, et al.
Publicado: (2014)

Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in a young patient presenting with a large uterus: A case report and review of the literature
por: Shero, Nora, et al.
Publicado: (2023)

Hereditary Leiomyomatosis and Renal Cell Cancer: Recent Insights Into Mechanisms and Systemic Treatment
por: Zhang, Congwang, et al.
Publicado: (2021)

A sheep in wolf's clothing; a case of renal leiomyoma masquerading as hereditary leiomyomatosis and renal cell carcinoma
por: Uzzo, Nicole, et al.
Publicado: (2023)

Hereditary Leiomyomatosis and Renal Cell Cancer
por: HANSEN, Anders Würgler, et al.
Publicado: (2020)

A novel case of hereditary leiomyomatosis- associated renal cell carcinoma with metastasis to pituitary gland
por: Palma, Catalina A., et al.
Publicado: (2022)

Birt-Hogg-Dubé Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes
por: Al-Shinnag, Mohammad, et al.
Publicado: (2021)

A Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma
por: Mehrtens, Sarah, et al.
Publicado: (2016)

A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata
por: Shi, Yue, et al.
Publicado: (2023)

Concurrent renal-cell carcinoma and cutaneous leiomyomas: A case of HLRCC
por: Fondriest, Sara A., et al.
Publicado: (2015)

A Non-Hereditary Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome
por: Kapila, Vaishali, et al.
Publicado: (2021)

Hereditary leiomyomatosis and renal cell carcinoma: Case report and review of the literature
por: Natália, Ferreira, et al.
Publicado: (2018)

Intravenous caval leiomyomatosis in the setting of renal cell carcinoma – A case report
por: Ceballos, Brian, et al.
Publicado: (2022)

Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review
por: Chayed, Zahraa, et al.
Publicado: (2021)

Hereditary Leiomyomatosis and Renal Cell Carcinoma: A Case Report and Review of the Literature
por: Alrawaf, Faisal A, et al.
Publicado: (2022)

Dermatologists might be the first to suspect hereditary leiomyomatosis and renal cell carcinoma syndrome()
por: González-Guerra, Elena, et al.
Publicado: (2023)

Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids
por: Bortoletto, Pietro, et al.
Publicado: (2017)

Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
por: Chaucer, Benjamin, et al.
Publicado: (2018)

Hereditary Leiomyomatosis and Renal Cell Cancer: A Case Report of Pilar Leiomyomatosis with History of Kidney Cancer and Review of the Literature
por: Kim, Jee-Woo, et al.
Publicado: (2023)

Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization
por: Sánchez-Heras, A. Beatriz, et al.
Publicado: (2020)

Hereditary leiomyomatosis and renal cell cancer syndrome – case report and review of the literature
por: Popa, Liliana Gabriela, et al.
Publicado: (2020)

Hereditary Leiomyomatosis and Renal Cell Cancer-Recognizing Patterns May Save Lives
por: Catarina, Tavares, et al.
Publicado: (2022)

Post-transplant diagnosis of hereditary leiomyomatosis and renal cell carcinoma syndrome in a kidney donor
por: Lee, Jonathan J., et al.
Publicado: (2014)

Hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report and implications of early onset
por: Çaliskan, Ercan, et al.
Publicado: (2017)

The preliminary outcome of the combination of immunotherapy and targeted therapy after recurrence and metastasis for hereditary leiomyomatosis and renal cell cancer—a case report
por: Feng, Dechao, et al.
Publicado: (2020)

Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients
por: Seo, Ja Young, et al.
Publicado: (2021)

Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients
por: Bateman, Nicholas W., et al.
Publicado: (2021)

Stereotactic body radiotherapy-induced abscopal effect twice after pembrolizumab failure in hereditary leiomyomatosis and renal cell carcinoma: a case report with genetic and immunologic analysis
por: Zhang, Xinyue, et al.
Publicado: (2021)

A novel pathogenic variant of the FH gene in a family with hereditary leiomyomatosis and renal cell carcinoma
por: Yagi, Yasuto, et al.
Publicado: (2022)

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports
por: Tucker, Matthew D., et al.
Publicado: (2020)

Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction
por: Kerins, Michael J., et al.
Publicado: (2018)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
por: Yang, Youfeng, et al.
Publicado: (2013)

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients
por: Choi, Yeonjoo, et al.
Publicado: (2019)

Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance
por: van Spaendonck-Zwarts, Karin Y., et al.
Publicado: (2011)

The role of immunotherapy in non-clear cell renal cell carcinoma
por: Climent, Carla, et al.
Publicado: (2023)

Case report: Going through pregnancy safely after twice partial nephrectomy for bilateral kidneys with HLRCC-associated RCC
por: Dai, Kunhan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vpab1hck652lsb0v5c8rovfgha